RESP

Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models

Eur Respir J. 2021 Sep 9:2101186. doi: 10.1183/13993003.01186-2021

Development and validation of the Evaluation Platform In COPD (EPIC): a population-based outcomes model of COPD for Canada

Med Decis Making. 2019 Feb;39(2):152-16

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?

Eur Respir J. 2020 Aug 27;2002122. doi: 10.1183/13993003.02122-2020.

The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study

This Lancet Respiratory Medicine describes a new prediction model to predict COPD exacerbations using simple clinical predictors

Cost-Effectiveness of Case Detection Strategies for the Early Detection of COPD

Primary care-based programs for improving the early detection of COPD are very likely to be cost-effective with high adherence to guideline-recommended treatment following diagnosis.

Primary care-based programs for improving the early detection of COPD are very likely to be cost-effective with high adherence t...

The association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic model

Am J Epidemiol. 2016;184(9):681–689

Individualized prediction of lung-function decline in chronic obstructive pulmonary disease

CMAJ. 2016;188(14):1004–1011

The Impact of Care Specialty on Survival-Adjusted Medical Costs of COPD Patients After a Hospitalization: a longitudinal analysis.

J Gen Intern Med. 2018 Sep;33(9):1528-1535

History of Asthma in Patients with Chronic Obstructive Pulmonary Disease: A Comparative Study of Economic Burden.

Ann Am Thorac Soc. 2016 Feb;13(2):188-96

Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study

Arch Osteoporos. 2018 Oct 29;13(1):116

The diagnostic performance of patient symptoms in screening for COPD

Respir Res. 2018 Feb 7;19(1):26

Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis

Respir Res. 2018 Feb 7;19(1):26

COPD: undefeated!

Chest. 2015 Apr;147(4):868-869

The global economic burden of asthma and chronic obstructive pulmonary disease

Int J Tuberc Lung Dis. 2016 Jan;20(1):11-23

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.

PLoS One. 2012;7(10):e46746

Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Lancet Respir Med. 2015 Aug;3(8):631-9

The Projected Epidemic Of COPD Hospitalizations Over the Next 15 Years: A Population Based Perspective

Am J Respir Crit Care Med. 2017 Feb 1;195(3):287-291

Excess economic burden of comorbidities in COPD: a 15-year population-based study

Eur Respir J. 2017 Jul 27;50(1). pii: 1700393

Heterogeneity’s ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations

Thorax. 2014 Nov;69(11):1043-4

A systematic review of health economics simulation models of chronic obstructive pulmonary disease

Value Health. 2017;20(1):152–162

Predicting severe COPD exacerbations: A population surveillance approach with administrative data

Under review

An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population

Chest. 2019 Sep 19. pii: S0012-3692(19)33868-1

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada

Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:2003-2013

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.

Using robust statistical methodology that controlled for heterogeneity in exacerbation rates among individuals, we demonstrated potential causal associations among past and future severe exacerbations, albeit the magnitude of association was noticeably low...

Using robust statistical methodology that controlled for heterogeneity in exacerbation rates among individuals, we demonstrated...

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine Respiratory Evaluation Sciences Program

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine
Respiratory Evaluation Sciences Program